🤩 FibriCheck is now FDA-cleared! We’re happy to announce an important stepping stone in our U.S. development, as FibriCheck’s ecosystem got FDA-cleared! This includes clearance for our patient-facing app, our AI-powered algorithm, and our healthcare provider portal. The FDA-clearance is an important mark that underlines the quality and accuracy of our technology, especially as FibriCheck received its clearance in the same category as smartphone ECG-devices. This makes FibriCheck the only device-agnostic solution using PPG-technology that is FDA-cleared with equivalence to ECG. Read more about our FDA-clearance in our latest newsletter!
FibriCheck
Medical Equipment Manufacturing
Hasselt, Limburg 5,455 followers
CE-, FDA- & TGA-approved medical app capable of detecting heart rhythm disorders
About us
FibriCheck is an innovative digital health company dedicated to transforming the way cardiac care is delivered. We do so by providing a medically certified, software-only and device-agnostic solution that redefines the way cardiac arrhythmias are detected and managed. We empower people to take control of their heart health by offering them our PPG-technology in a user-friendly setting. Users can measure their heart rhythm in 60 seconds, using the camera of their smartphone without any additional hardware. These measurements provide valuable insights into the heart rhythm which help people attain peace of mind and help to improve the outcomes of cardiac arrhythmias by speeding up the process of getting the right diagnosis and treatment. FibriCheck can be used throughout the entire patient lifecycle, from early detection and secondary prevention to the management of cardiac arrhythmias, such as atrial fibrillation (AF). On top of that, our software can also be used for symptom management such as palpitations, as symptoms can be logged with each measurement. These symptoms are combined with the results of the measurements in reports, which can easily be shared with physicians for further follow-up. Accuracy and safety are of the highest importance to us, which is why we make continuous efforts towards regulatory compliance and clinical validation. We are a CE class IIa medical device with regulatory approvals of the MHRA, FDA and TGA. FibriCheck is currently implemented by over 2000 clinical practices, and is the trusted partner in heart health for over 1 million users in 43 countries. Various integration possibilities are available. 📚 Want to learn about PPG-technology from our experts? bit.ly/3XmqU7r 🧑🏫 Curious about our clinical studies? bit.ly/3XkghCj 🤝 Interested in collaborating with FibriCheck? bit.ly/43h0UwQ 💡 Want to receive the latest news and product updates? bit.ly/3MF0ybM 🫶 We're always looking for ambitious people: bit.ly/30cT6gw
- Website
-
http://www.fibricheck.com
External link for FibriCheck
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Hasselt, Limburg
- Type
- Public Company
- Founded
- 2014
- Specialties
- Mobile Applications, eHealth, Atrial Fibrillation, Digital Health, CE Certification, Remote Monitoring, Smartphone, Wearable, Services, Algorithms, Data science, HealthTech, MedTech, PPG, Arrhythmias, and mHealth
Products
FibriCheck
Medical Device Integration Software
FibriCheck is a medically approved, clinical-grade smartphone app that offers heart health assessments using vital parameters such as heart rate, heart rhythm, blood pressure and weight. With FibriCheck, users are empowered to detect and monitor cardiac arrhythmias, including atrial fibrillation, wherever and whenever they want without the need for additional hardware. Healthcare professionals can gain valuable insights from our reliable, AI-powered PPG measurement results. By facilitating informed clinical decision-making and timely interventions, we can help streamline the way cardiac care is delivered. The FibriCheck app can be used on its own, but can also be fully integrated into partner platforms or applications, which allows us to enable customised care pathways that streamline clinical care and drive cost efficiency.
Locations
-
Primary
Kempische steenweg 311
Hal A
Hasselt, Limburg 3500, BE
Employees at FibriCheck
Updates
-
💡 AFib Awareness Month: How digital tools empower clinicians Atrial fibrillation (AFib) is the most commonly sustained heart rhythm disorder. By 2060, it is projected to affect 17.9 million people in Europe and 15.9 million in the US by 2050. Yet many cases remain undiagnosed until serious complications such as stroke occur. An increasing amount of diagnosed cases on the other hand need to be followed up, which puts enormous strain on the healthcare system. This month, the Heart Rhythm Society emphasizes the need for greater awareness, education, and action. At FibriCheck, we believe digital health can play a crucial role in supporting clinicians to improve early detection, optimize treatment, and streamline AFib care pathways. Our implementations demonstrate that: ✅ FibriCheck significantly increases efficiency of AFib pathways, resulting in substantial time savings. ✅ Population campaigns with FibriCheck empower thousands of individuals, raising awareness and enabling timely detection. ✅ Health insurers see measurable value when digital monitoring tools are integrated into care packages. ✅ Clinicians can monitor patients effectively before and after treatment, enabling more informed and timely decision-making. ✅ Outpatient AFib management with FibriCheck helps reduce waiting lists, costs, and logistical burden. Let’s collaborate to ensure no patient slips through the cracks. Together, we can raise awareness, improve care, and change lives. 👉 Connect with us via info@fibricheck.com to explore how FibriCheck can strengthen your AFib pathway.
-
Patients of the Spaarne Gasthuis can now use FibriCheck within RPM platform Sananet! Thanks to this integration, patients can measure their heart rate and heart rhythm with their own smartphone device. Results are shared immediately with their caregivers via their electronic health record, ensuring thorough follow-up and efficient care management!
𝗦𝗮𝗺𝗲𝗻 𝗱𝗶𝗴𝗶𝘁𝗮𝗹𝗲 𝘇𝗼𝗿𝗴 𝘃𝗼𝗿𝗺𝗴𝗲𝘃𝗲𝗻 𝗺𝗲𝘁 𝗵𝗲𝘁 𝗦𝗽𝗮𝗮𝗿𝗻𝗲 𝗚𝗮𝘀𝘁𝗵𝘂𝗶𝘀 Het Spaarne Gasthuis is gestart met de 𝗦𝗮𝗻𝗮𝗖𝗼𝗮𝗰𝗵 𝗕𝗼𝗲𝘇𝗲𝗺𝗳𝗶𝗯𝗿𝗶𝗹𝗹𝗲𝗿𝗲𝗻. Het ziekenhuis heeft actief mee ontwikkeld aan deze digitale coach die patiënten ondersteunt in hun dagelijks leven. Dankzij de samenwerking met The Med Company B.V. en FibriCheck kunnen patiënten hun hartritme eenvoudig thuis volgen, terwijl artsen snel kunnen ingrijpen wanneer nodig. Lees meer over waarom en hoe patiënten en zorgverleners samen deze innovatieve digitale zorg hebben vormgeven: https://lnkd.in/eTJpY8tK
-
🤩 We’re looking back on a great edition of HRX full of insightful discussions on the evolving role of PPG in diagnostics, with many presentations on stage featuring FibriCheck and PPG. We’re grateful for the many new connections we made and the chance to reconnect with familiar faces. Our booth was buzzing with other innovators that want to improve the future of heart health, which keeps us pushing forward. Some key takeaways from studies featuring FibriCheck as presented at #HRX2025: 🚀 A virtual AF ward using the FibriCheck app proved clinically safe, reduced hospital stays and readmissions, improved patient/staff satisfaction, and can save the NHS over £200k in one year. 🚀Several studies showed that FibriCheck has comparable accuracy (99.8%) in detecting AF recurrence and even surpassing yield compared to conventional monitoring (25.7% vs 5.4% AF recurrence detected after AF ablation) As we reflect on HRX, one thing is clear: PPG is shaping the future of diagnostics. Want to know more about how we leverage this technology? Get in touch via info@fibricheck.com
-
-
Heading to the Global EP Event? Let’s Connect! 🫶 We’re excited to join expert electrophysiologists to discuss the latest innovations in heart health and to explore how we can shape the future of cardiac care together. 💡 What makes FibriCheck unique in EP care? ✅ Device-free, scalable AF monitoring ✅ Accuracy comparable to leading ECG devices ✅ Billable and fully integrated solution ✅ Proven value in pre- and post-treatment pathways Already curious? Discover how FibriCheck can support your post-PFA pathway and schedule a meeting during the event by reaching out to Margaux Casteur. Cleveland Clinic
-
-
This incredible #HRX2025 edition is coming to an end with a must-see session! At 10.45 AM, Myrte Barthels will present the Moderated AbstracX Session “Deep Learning-Based Identification of Latent Paroxysmal AF from Real-World Smartphone Acquired PPG in Sinus Rhythm”. Join the session and see how deep learning is unlocking new possibilities for the detection of AF! We’re available at the event at booth 202 for any questions you may have regarding FibriCheck. Lars Grieten Bieke Van Gorp Stijn Evens Margaux Casteur
-
-
Today we are ready for another interesting day at #HRX2025 packed with FibriCheck-featured sessions! 📍 1:15 PM: HRX roundtable - FHIR in action: bridging CIED and wearable interoperability through CardX 📍 3:45 PM: Moderated AbstracX Session- Is a virtual atrial fibrillation pathway using a smartphone application effective? A single centre experience. 📍 6:05 PM: AbstracX Happy Hour Sessions - Evaluation of photoplethysmography-based smartphone app accuracy for detecting atrial fibrillation after ablation 📍 6:15 PM: AbstracX Happy Hour Sessions - Detection of atrial fibrillation recurrence post-ablation using photoplethysmography-based smartphone app Which sessions are you most excited about? Let us know in the comments. If you are at HRX, make sure to stop by our booth 202 or send a message to Margaux Casteur to meet up at the event.
-
The FibriCheck team is kicking off #HRX2025 today. We’re excited to connect with other innovators in the heart health space and to attend the following sessions: 📍 4.30 PM: HRX roundtable - Innovation in PPG technology 📍 5:35 PM: AbstracX Happy hour Sessions - AI-predicted ECG age gap as a biomarker: bias-adjusted correlation with mortality and cardiovascular risk factors Join us to explore the future of PPG technology and see how AI-driven insights can transform cardiovascular care. 👋 Will you be present at HRX? Reach out to Margaux Casteur to grab a coffee or visit our booth 202 directly!
-
Our latest newsletter is here! Discover how our algorithm update is making an impact and what our key takeaways were from #ESC2025. 💡
-
The FibriCheck team is ready for HRX 2025 and is eager to talk all things AF innovation! Stop by booth 202 to find out more about how our device-free monitoring technology with ECG-level accuracy can fit seamlessly in your workflow. Want to plan a meeting? Send Margaux Casteur a message via LinkedIn! After the first day of #HRX2025, we're hosting FibriCheck Connect, an informal get-together between colleagues, collaborators and fellow innovators. You can join us by confirming your attendance: http://bit.ly/4nboOTA Lars Grieten Bieke Van Gorp Stijn Evens
-